Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple SclerosisPeter Alping, Joachim Burman, Jan Lycke, Thomas Frisell, and Fredrik PiehlNeurology - March 2021